IN-DATE
5343230: Bard GlidePath LT Hemodialysis Catheter, Straight, Standard Kit 13F x 23cm-28cm
Sign in to add this product to your favorites!
| Price: | $65.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 3 eaches |
| Expiration: | 09-2026 |
AccessGUDID Info
- FDA Product Code: MSD
- FDA Product Code Name: Catheter, hemodialysis, implanted
- GMDN Term Code: 37278
- GMDN Term Name: Double-lumen haemodialysis catheter, implantable
- GMDN Term Description: An implantable, flexible, double-lumen tube intended to be used for chronic or long-term (> 30 days) vascular access, primarily during haemodialysis, to conduct blood from a patient and returning it after extracorporeal circulation; it may also be used during haemoperfusion and/or apheresis. It is intended for coaxial flow of blood, may be radiopaque, coated with heparin to prevent thrombus formation, and/or include a silver-coated sleeve to retard bacterial growth; devices dedicated to catheter introduction/function (e.g., introducer needle) may be included.
Manufacturer
Becton, Dickinson and Company (BD) is a global medical technology leader providing a broad range of products across medication management, diagnostics, and surgical care. BD’s Medical segment includes industry-leading solutions in medication delivery, such as BD syringes, needles, and infusion systems, as well as devices for diabetes care and pharmaceutical pre-fillable systems. The Life Sciences division supports clinical diagnostics and research with products like BD Vacutainer blood collection systems and BD Veritor rapid testing platforms. BD’s Interventional segment includes advanced surgical products from acquired brands like Bard and Tepha, with specialties in infection prevention, hernia repair, biosurgery, and urology. With a focus on advancing health through technology, BD supports hospitals, labs, and clinicians worldwide in improving safety, efficiency, and patient outcomes.
